- Home
- GNS vs COCP Comparison
GNS vs COCP Comparison
Compare GNS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- COCP
- Stock Information
- Founded
- GNS 2002
- COCP N/A
- Country
- GNS Singapore
- COCP United States
- Employees
- GNS 307
- COCP N/A
- Industry
- GNS Other Consumer Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- COCP Health Care
- Exchange
- GNS Nasdaq
- COCP Nasdaq
- Market Cap
- GNS 14.5M
- COCP 18.3M
- IPO Year
- GNS 2022
- COCP N/A
- Fundamental
- Price
- GNS $0.69
- COCP $1.99
- Analyst Decision
- GNS
- COCP Strong Buy
- Analyst Count
- GNS 0
- COCP 1
- Target Price
- GNS N/A
- COCP $7.00
- AVG Volume (30 Days)
- GNS 5.5M
- COCP 14.9K
- Earning Date
- GNS 12-24-2024
- COCP 11-13-2024
- Dividend Yield
- GNS N/A
- COCP N/A
- EPS Growth
- GNS N/A
- COCP N/A
- EPS
- GNS N/A
- COCP N/A
- Revenue
- GNS $23,062,754.00
- COCP N/A
- Revenue This Year
- GNS $39.87
- COCP N/A
- Revenue Next Year
- GNS $32.96
- COCP N/A
- P/E Ratio
- GNS N/A
- COCP N/A
- Revenue Growth
- GNS 26.76
- COCP N/A
- 52 Week Low
- GNS $0.51
- COCP $1.33
- 52 Week High
- GNS $9.49
- COCP $3.10
- Technical
- Relative Strength Index (RSI)
- GNS 42.21
- COCP 51.27
- Support Level
- GNS $0.68
- COCP $1.83
- Resistance Level
- GNS $0.80
- COCP $2.07
- Average True Range (ATR)
- GNS 0.10
- COCP 0.11
- MACD
- GNS -0.01
- COCP -0.01
- Stochastic Oscillator
- GNS 15.70
- COCP 44.74
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).